Ignite Creation Date:
2024-05-06 @ 3:11 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02227953
Status:
UNKNOWN
Last Update Posted:
2014-09-03
First Post:
2014-08-26
Brief Title:
A Pilot Study of tDCS for Mild to Moderate Alzhemiers Disease
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
A Pilot Study for the Improvement of Cognitive Function ADAS-Cog 11 After Transcranial Direct Current Stimulation in Mild to Moderate Alzheimers Disease
Status:
UNKNOWN
Status Verified Date:
2014-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this preliminary study is to investigate whether the transcranial direct current stimulation tDCS improves the cognitive function in patients with Alzheimers disease
Detailed Description:
Twenty patients were recruited and randomized to receive either real or sham-tDCS over the left anode and right cathode dorsolateral prefrontal cortex DLPFC Their legally responsible caregivers were provided with mobile tDCS device and were instructed to use it on the patients at home 30-minute session of the stimulation were applied everyday in the morning for 12 weeks The patients were evaluated at baseline at week 6 and 12
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None